Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of JMKX000623 and Metformin in Healthy Volunteers
NCT06066060Phase 1Completed
- Sponsor
- Jemincare
- Start
- Sep 2023
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of JMKX000623 in diabetic polyneuropathy (DPN), sponsored by Jemincare. Primary endpoints: Area Under the Dosing Time Curve During the Dosing Interval After Reaching Steady State and Maximum observed After Reaching steady state concentration. Started Sep 2023; status: completed.
02
Drugs
JMKX000623
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT06066060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06066060.